Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 28, 2024JAMA Otolaryngology–Head & Neck Surgery

Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

EKEmily KimCalifornia State University, San MarcosEREmily S. RuizBrigham and Women's HospitalMDMia S. DeSimoneBrigham and Women's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e71ec4b6db643587698218https://doi.org/10.1001/jamaoto.2024.0259
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck2023 · 25 citations
  2. 2Cutaneous Squamous-Cell Carcinoma2001 · 1,315 citations
  3. 3Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the US Population, 20122015 · 1,851 citations